Skip to content

Effect of gradual withdraw of remifentanil combined with postoperative pumping on postoperative nociceptive hypersensitivity in patients undergoing laparoscopic total hysterectomy

Effect of gradual withdraw of remifentanil combined with postoperative pumping on postoperative nociceptive hypersensitivity in patients undergoing laparoscopic total hysterectomy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074524
Enrollment
Unknown
Registered
2023-08-09
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperalgesia

Interventions

High-dose remifentanil group:Intraoperatively, remifentanil was infused continuously at a rate of 0.3 µg/(kg-min) and discontinued at the end of the sutured skin,20 mL of saline was pumped for 30 minu
Gradual withdraw of high dose remifentanil:The intraoperative infusion of remifentanil was continued at a rate of 0.3 µg/(kg-min), adjusted to 0.2 µg/(kg-min) 30 min before the expected end of the pro
High dose remifentanil plus post-operative pumping group:Intraoperatively, remifentanil was infused continuously at a rate of 0.3 µg/(kg-min) and stopped at the end of the sutured skin. 1ug/kg of remi
Gradual withdraw of high dose remifentanil plus post-operative pumping group:The intraoperative infusion of remifentanil was continued at a rate of 0.3 µg/(kg-min), which was adjusted to 0.2 µg/(kg-mi

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients undergoing elective laparoscopic total hysterectomy for gynaecological conditions 2. age 18 ~ 65 years; 3. ASA class I-II; 4. BMI 18-30 kg/m2; 5. voluntarily participated in the trial and signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. the presence of contraindications to surgery or anaesthesia 2. the presence of allergy to or contraindication to the use of remifentanil 3. the presence of a history of neuropsychiatric disorders, drug and alcohol abuse 4. those with a combination of severe cardiovascular, cerebrovascular, gastrointestinal, respiratory, haematological or neurological disorders 5. the use of opioids or other analgesic drugs within 48h prior to surgery 6. those with symptoms associated with peripheral or central neuropathy, a history of chronic pain

Design outcomes

Primary

MeasureTime frame
Mechanical pain thresholds;

Secondary

MeasureTime frame
Pain score;Restoring quality scores;Wakefulness mania score;Ramsay Sedation Score;Postoperative extubation time;Postoperative awakening time;Time of first post-operative venting;Total post-operative hospital stay;

Countries

China

Contacts

Public ContactFang Gao

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

1458089673@qq.com+86 158 6216 8178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026